Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Net Margin (2016 - 2026)

Avanos Medical's Net Margin history spans 11 years, with the latest figure at 0.17% for Q4 2024.

  • On a quarterly basis, Net Margin rose 12.0% to 0.17% in Q4 2024 year-over-year; TTM through Sep 2025 was 0.04%, a 84.0% increase, with the full-year FY2024 number at 0.84%, up 687.0% from a year prior.
  • Net Margin hit 0.17% in Q4 2024 for Avanos Medical, up from 0.94% in the prior quarter.
  • Over the last five years, Net Margin for AVNS hit a ceiling of 20.65% in Q2 2021 and a floor of 71.79% in Q4 2021.
  • Historically, Net Margin has averaged 5.53% across 5 years, with a median of 0.23% in 2023.
  • Biggest five-year swings in Net Margin: plummeted -4530bps in 2021 and later skyrocketed 7575bps in 2022.
  • Tracing AVNS's Net Margin over 5 years: stood at 26.49% in 2020, then crashed by -171bps to 71.79% in 2021, then skyrocketed by 106bps to 3.96% in 2022, then tumbled by -107bps to 0.29% in 2023, then surged by 42bps to 0.17% in 2024.
  • Business Quant data shows Net Margin for AVNS at 0.17% in Q4 2024, 0.94% in Q3 2024, and 1.46% in Q2 2024.